EGFR and lung cancer: Examples of targeted therapies include small molecule inhibitors of the epidermal growth factor receptor (EGFR) pathway in lung cancer (e.g. erlotinib (Tarceva)) and inhibitors of the BCR-ABL tyrosine kinase in chronic myeloid leukemia (e.g. imatinib (Gleevec), dasatinib (Sprycel), and nilotinib (Tasigna)).